Cannabis
Delota Corp. Announces Grant of Options And RSUs
Vaughan, Ontario–(Newsfile Corp. – July 11, 2023) – Delota Corp. (CSE: LOTA) (“Delota” or the “Company“) an established Canadian vape and cannabis retailer, is pleased to announce the grant of stock options (each an “Option“) and restricted share units (each an “RSU“) pursuant to the Company’s omnibus plan (the “Plan“).
The Company has granted an aggregate of 1,710,000 Options and an aggregate of 640,000 RSUs to certain directors, officers, employees, and consultants of the Company. Each Option is exercisable at a price of $0.11 per common share, expires four years from the date of grant and vests immediately. Each Option is exercisable to purchase one common share in the capital of the Company. Each RSU granted vests immediately. All of the Options and RSUs (and any common shares issuable upon exercise thereof) will be subject to a four month and one day hold period pursuant to the polices of the Canadian Securities Exchange and applicable securities laws.
About Delota Corp.
Delota is an established vape and cannabis retailer that curates and sells vape and nicotine-related products, other smoking cessation products, cannabis products, and accessories where regulations permit. The Company currently operates 28 brick-and-mortar specialty vape stores in Ontario under the 180 Smoke Vape Store banner name, a leading Canada-wide specialty vape e-commerce platform (www.180smoke.ca), and five licensed dispensaries under the Offside Cannabis banner name in Ontario.
For further information, please contact:
Delota Corp.
Cameron Wickham
Executive Vice Chair and CEO
T: (905) 330-1602
E: [email protected]
Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/173066
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Cannabis2 weeks ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
transfer2 weeks ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis1 week ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis2 weeks ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
CCELL®2 weeks ago
CCELL Launches Environmentally Conscious Eco Star AIO Vaporizer
-
Innocan7 days ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf1 week ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis6 days ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care